- •
Assess each colorectal cancer patient for their degree of fitness and tailor the aggressiveness of the treatment appropriately.
- •
The goals of care, curative versus palliative, should guide therapeutic management.
- •
Employ strategies such as intermittent oxaliplatin or omission of bolus 5-fluorouracil to improve chemotherapy tolerance for older adults.
Management of Colorectal Cancer in Older Adults
Section snippets
Key points
Colorectal cancer screening
Although more than one-third of CRC cases occur in patients 75 years or older, the age at which colon cancer screening should be discontinued remains an area of debate. The U.S. Preventative Services Task Force recommends against the routine use of screening colonoscopy among patients aged 76 to 85, and recommends against any CRC screening in patients over 85 years.7 This is owing to the increased risks of colonoscopy, including perforation, gastrointestinal bleeding, and cardiopulmonary
Surgery
More than 70% of CRC cases are diagnosed at early stages (I–III) and therefore amenable to operative resection.8 Surgery for CRC is usually well-tolerated among the elderly, especially with advances in laparoscopic colectomy, which result in similar postoperative complications (death, anastomotic leak, and postoperative ileus) among younger and older patients.9 Excellent survival results can be achieved even among the oldest patients. A recent analysis of the Surveillance, Epidemiology and End
Rectal cancer
The current standard of care in the management of locally advanced rectal cancer, including lesions that have invaded through the muscularis propria and/or lymph node positive disease found on either pelvic MRI or rectal endoscopic ultrasonography, is for neoadjuvant chemotherapy with a fluoropyrimidine followed by operative resection plus 4 more months of additional chemotherapy.15 Patients over 75 years of age are at risk of early termination of treatment, treatment interruptions, and dose
Systemic therapy for colorectal cancer
The use of systemic chemotherapy improves survival after operative resection of CRC (adjuvant setting) as well as when surgery is unable to be performed (palliative setting). Multiple studies have shown that older adults with CRC are undertreated in both the adjuvant as well as the metastatic setting.5, 18, 19 Undertreating older adults with systemic chemotherapy may decrease survival outcomes in this age group. Several database studies have shown that older patients with CRC who receive
References (68)
- et al.
Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis
Clin Colorectal Cancer
(2005) - et al.
Difficulties in decision making regarding chemotherapy for older cancer patients: a census of cancer physicians
Crit Rev Oncol Hematol
(2011) - et al.
Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983
Eur J Cancer
(2014) - et al.
Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older
Int J Radiat Oncol Biol Phys
(2011) - et al.
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial
Ann Oncol
(2003) - et al.
Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
Lancet
(2011) - et al.
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials
Ann Oncol
(2015) - et al.
FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study
Arch Gerontol Geriatr
(2011) - et al.
Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer
J Geriatr Oncol
(2013) - et al.
Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study
Clin Colorectal Cancer
(2005)
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
Lancet Oncol
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
Lancet Oncol
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials
Eur J Cancer
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer
Crit Rev Oncol Hematol
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Lancet
Global cancer statistics, 2012
CA Cancer J Clin
Refining the chemotherapy approach for older patients with colon cancer
J Clin Oncol
Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer
Oncologist
Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer
J Clin Oncol
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement
Ann Intern Med
Surgical considerations in older adults with cancer
J Clin Oncol
Laparoscopic versus open colorectal resection in the elderly population
Surg Endosc
Predictors of short-term postoperative survival after elective colectomy in colon cancer patients >/= 80 years of age
Ann Surg Oncol
Elderly POSSUM, a dedicated score for prediction of mortality and morbidity after major colorectal surgery in older patients
Br J Surg
Resection of colorectal liver metastases in the elderly: does age matter?
Colorectal Dis
Safety and efficacy of hepatectomy for colorectal metastases in the elderly
J Surg Oncol
Preoperative versus postoperative chemoradiotherapy for rectal cancer
N Engl J Med
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04
J Clin Oncol
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer
JAMA
Age and adjuvant chemotherapy use after surgery for stage III colon cancer
J Natl Cancer Inst
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years
J Clin Oncol
Duration of adjuvant chemotherapy for colon cancer and survival among the elderly
J Clin Oncol
Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations
J Clin Oncol
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
N Engl J Med
Cited by (16)
Laparoscopic versus open colectomy for obstructing right colon cancer: A systematic review and meta-analysis
2017, Journal of Visceral SurgeryCitation Excerpt :The surgical strategy for patients with bowel obstruction from right colon cancer differs according to the cancer location, staging, ASA score, comorbidities and the skills of the emergency surgeon [6–9]. The need for emergency surgery is more frequent in the elderly (especially in patients aged more than 75 years), and these patients are generally frail due to a significant incidence of comorbidities, thus they are affected by higher rates of postoperative morbidity and mortality [10,11]. The prognosis of patients treated in emergency setting is expectedly worse than those treated in elective setting [12–15].
Gastrointestinal Disturbances in the Elderly
2017, Nursing Clinics of North AmericaCitation Excerpt :The clinician and patient should discuss which method of screening is the best option for individualized patients. Treatment for CRC can include a single or combination of surgery, chemotherapy, or radiation.39 An observed 30% to 40% decline in liver size, blood flow, and perfusion is noted between the third and tenth decades of life.5
Quality of life preferences in colorectal cancer patients aged 80 and over
2021, ANZ Journal of Surgery7-chloro-4-(Phenylselanyl) quinoline reduces renal oxidative stress induced by oxaliplatin in mice
2021, Canadian Journal of Physiology and Pharmacology
Financial Disclosure: Dr J.M. Hubbard receives research support for clinical trials from Genentech, Bayer, Boston Biomedical Inc, and Senhwa Biosciences Inc. Advisory board for Bayer (Honorarium to Mayo Clinic).